Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Integrated health system strengthening can generate rapid population impacts that can be replicated: lessons from Rwanda to Madagascar.

Bonds MH, Rich ML.

BMJ Glob Health. 2018 Oct 1;3(5):e000976. doi: 10.1136/bmjgh-2018-000976. eCollection 2018. No abstract available.

2.

Early changes in intervention coverage and mortality rates following the implementation of an integrated health system intervention in Madagascar.

Garchitorena A, Miller AC, Cordier LF, Rabeza VR, Randriamanambintsoa M, Razanadrakato HR, Hall L, Gikic D, Haruna J, McCarty M, Randrianambinina A, Thomson DR, Atwood S, Rich ML, Murray MB, Ratsirarson J, Ouenzar MA, Bonds MH.

BMJ Glob Health. 2018 Jun 4;3(3):e000762. doi: 10.1136/bmjgh-2018-000762. eCollection 2018.

3.

Impact of a health system strengthening intervention on maternal and child health outputs and outcomes in rural Rwanda 2005-2010.

Thomson DR, Amoroso C, Atwood S, Bonds MH, Rwabukwisi FC, Drobac P, Finnegan KE, Farmer DB, Farmer PE, Habinshuti A, Hirschhorn LR, Manzi A, Niyigena P, Rich ML, Stulac S, Murray MB, Binagwaho A.

BMJ Glob Health. 2018 Apr 9;3(2):e000674. doi: 10.1136/bmjgh-2017-000674. eCollection 2018.

4.

Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis.

Cox V, Brigden G, Crespo RH, Lessem E, Lynch S, Rich ML, Waning B, Furin J.

Int J Tuberc Lung Dis. 2018 Apr 1;22(4):407-412. doi: 10.5588/ijtld.17.0706.

PMID:
29562988
5.

Madagascar can build stronger health systems to fight plague and prevent the next epidemic.

Bonds MH, Ouenzar MA, Garchitorena A, Cordier LF, McCarty MG, Rich ML, Andriamihaja B, Haruna J, Farmer PE.

PLoS Negl Trop Dis. 2018 Jan 4;12(1):e0006131. doi: 10.1371/journal.pntd.0006131. eCollection 2018 Jan. No abstract available.

6.

Shortened multidrug-resistant tuberculosis treatment in settings with a high prevalence of ofloxacin resistance.

Guglielmetti L, Varaine F, Huerga H, Bonnet M, Rich ML, Mitnick CD.

Eur Respir J. 2017 Jul 20;50(1). pii: 1700598. doi: 10.1183/13993003.00598-2017. Print 2017 Jul. No abstract available.

7.

Baseline population health conditions ahead of a health system strengthening program in rural Madagascar.

Miller AC, Ramananjato RH, Garchitorena A, Rabeza VR, Gikic D, Cripps A, Cordier L, Rahaniraka Razanadrakato HT, Randriamanambintsoa M, Hall L, Murray M, Safara Razanavololo F, Rich ML, Bonds MH.

Glob Health Action. 2017;10(1):1329961. doi: 10.1080/16549716.2017.1329961.

8.

Target regimen profiles for treatment of tuberculosis: a WHO document.

Lienhardt C, Nahid P, Rich ML, Bansbach C, Kendall EA, Churchyard G, González-Angulo L, D'Ambrosio L, Migliori GB, Raviglione M.

Eur Respir J. 2017 Jan 25;49(1). pii: 1602352. doi: 10.1183/13993003.02352-2016. Print 2017 Jan. No abstract available.

9.

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model.

Kendall EA, Shrestha S, Cohen T, Nuermberger E, Dooley KE, Gonzalez-Angulo L, Churchyard GJ, Nahid P, Rich ML, Bansbach C, Forissier T, Lienhardt C, Dowdy DW.

PLoS Med. 2017 Jan 3;14(1):e1002202. doi: 10.1371/journal.pmed.1002202. eCollection 2017 Jan.

10.

Totality of outcomes: A different paradigm in assessing interventions for treatment of tuberculosis.

Montepiedra G, Yuen CM, Rich ML, Evans SR.

J Clin Tuberc Other Mycobact Dis. 2016 Aug;4:9-13. doi: 10.1016/j.jctube.2016.05.004. No abstract available.

11.

Discordant Treatment Responses to Combination Antiretroviral Therapy in Rwanda: A Prospective Cohort Study.

Kayigamba FR, Franke MF, Bakker MI, Rodriguez CA, Bagiruwigize E, Wit FW, Rich ML, Schim van der Loeff MF.

PLoS One. 2016 Jul 20;11(7):e0159446. doi: 10.1371/journal.pone.0159446. eCollection 2016.

12.

Presumptive treatment of multidrug-resistant tuberculosis in household contacts.

Parr JB, Rich ML, Keshavjee S, Franke MF, Mitnick CD, Bayona J, Becerra MC.

Int J Tuberc Lung Dis. 2016 Mar;20(3):370-5. doi: 10.5588/ijtld.15.0433.

PMID:
27046719
13.

Motivations and Constraints to Family Planning: A Qualitative Study in Rwanda's Southern Kayonza District.

Farmer DB, Berman L, Ryan G, Habumugisha L, Basinga P, Nutt C, Kamali F, Ngizwenayo E, St Fleur J, Niyigena P, Ngabo F, Farmer PE, Rich ML.

Glob Health Sci Pract. 2015 May 13;3(2):242-54. doi: 10.9745/GHSP-D-14-00198.

14.

Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis.

Seung KJ, Keshavjee S, Rich ML.

Cold Spring Harb Perspect Med. 2015 Apr 27;5(9):a017863. doi: 10.1101/cshperspect.a017863. Review.

15.

Counting pyrazinamide in regimens for multidrug-resistant tuberculosis.

Franke MF, Becerra MC, Tierney DB, Rich ML, Bonilla C, Bayona J, McLaughlin MM, Mitnick CD.

Ann Am Thorac Soc. 2015 May;12(5):674-9. doi: 10.1513/AnnalsATS.201411-538OC.

16.

Data for Program Management: An Accuracy Assessment of Data Collected in Household Registers by Community Health Workers in Southern Kayonza, Rwanda.

Mitsunaga T, Hedt-Gauthier BL, Ngizwenayo E, Farmer DB, Gaju E, Drobac P, Basinga P, Hirschhorn L, Rich ML, Winch PJ, Ngabo F, Mugeni C.

J Community Health. 2015 Aug;40(4):625-32. doi: 10.1007/s10900-014-9977-9.

PMID:
25502593
17.

Depression, adherence and attrition from care in HIV-infected adults receiving antiretroviral therapy.

Krumme AA, Kaigamba F, Binagwaho A, Murray MB, Rich ML, Franke MF.

J Epidemiol Community Health. 2015 Mar;69(3):284-9. doi: 10.1136/jech-2014-204494. Epub 2014 Nov 10.

PMID:
25385745
18.

Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death.

Velásquez GE, Becerra MC, Gelmanova IY, Pasechnikov AD, Yedilbayev A, Shin SS, Andreev YG, Yanova G, Atwood SS, Mitnick CD, Franke MF, Rich ML, Keshavjee S.

Clin Infect Dis. 2014 Jul 1;59(1):9-15. doi: 10.1093/cid/ciu209. Epub 2014 Apr 11.

19.

Rwanda 20 years on: investing in life.

Binagwaho A, Farmer PE, Nsanzimana S, Karema C, Gasana M, de Dieu Ngirabega J, Ngabo F, Wagner CM, Nutt CT, Nyatanyi T, Gatera M, Kayiteshonga Y, Mugeni C, Mugwaneza P, Shema J, Uwaliraye P, Gaju E, Muhimpundu MA, Dushime T, Senyana F, Mazarati JB, Gaju CM, Tuyisenge L, Mutabazi V, Kyamanywa P, Rusanganwa V, Nyemazi JP, Umutoni A, Kankindi I, Ntizimira C, Ruton H, Mugume N, Nkunda D, Ndenga E, Mubiligi JM, Kakoma JB, Karita E, Sekabaraga C, Rusingiza E, Rich ML, Mukherjee JS, Rhatigan J, Cancedda C, Bertrand-Farmer D, Bukhman G, Stulac SN, Tapela NM, van der Hoof Holstein C, Shulman LN, Habinshuti A, Bonds MH, Wilkes MS, Lu C, Smith-Fawzi MC, Swain JD, Murphy MP, Ricks A, Kerry VB, Bush BP, Siegler RW, Stern CS, Sliney A, Nuthulaganti T, Karangwa I, Pegurri E, Dahl O, Drobac PC.

Lancet. 2014 Jul 26;384(9940):371-5. doi: 10.1016/S0140-6736(14)60574-2. Epub 2014 Apr 4.

20.

A simplified echocardiographic strategy for heart failure diagnosis and management within an integrated noncommunicable disease clinic at district hospital level for sub-Saharan Africa.

Kwan GF, Bukhman AK, Miller AC, Ngoga G, Mucumbitsi J, Bavuma C, Dusabeyezu S, Rich ML, Mutabazi F, Mutumbira C, Ngiruwera JP, Amoroso C, Ball E, Fraser HS, Hirschhorn LR, Farmer P, Rusingiza E, Bukhman G.

JACC Heart Fail. 2013 Jun;1(3):230-6. doi: 10.1016/j.jchf.2013.03.006. Epub 2013 Jun 3.

21.

Shared learning in an interconnected world: innovations to advance global health equity.

Binagwaho A, Nutt CT, Mutabazi V, Karema C, Nsanzimana S, Gasana M, Drobac PC, Rich ML, Uwaliraye P, Nyemazi JP, Murphy MR, Wagner CM, Makaka A, Ruton H, Mody GN, Zurovcik DR, Niconchuk JA, Mugeni C, Ngabo F, Ngirabega Jde D, Asiimwe A, Farmer PE.

Global Health. 2013 Aug 30;9:37. doi: 10.1186/1744-8603-9-37.

22.

Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality.

Mitnick CD, Franke MF, Rich ML, Alcantara Viru FA, Appleton SC, Atwood SS, Bayona JN, Bonilla CA, Chalco K, Fraser HS, Furin JJ, Guerra D, Hurtado RM, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Seung KJ, Shin SS, Sloutsky A, Tolman AW, Becerra MC.

PLoS One. 2013;8(3):e58664. doi: 10.1371/journal.pone.0058664. Epub 2013 Mar 13.

23.

Community-based accompaniment and psychosocial health outcomes in HIV-infected adults in Rwanda: a prospective study.

Thomson DR, Rich ML, Kaigamba F, Socci AR, Hakizamungu M, Bagiruwigize E, Binagwaho A, Franke MF.

AIDS Behav. 2014 Feb;18(2):368-80. doi: 10.1007/s10461-013-0431-2.

PMID:
23443977
24.

Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda.

Franke MF, Kaigamba F, Socci AR, Hakizamungu M, Patel A, Bagiruwigize E, Niyigena P, Walker KD, Epino H, Binagwaho A, Mukherjee J, Farmer PE, Rich ML.

Clin Infect Dis. 2013 May;56(9):1319-26. doi: 10.1093/cid/cis1193. Epub 2012 Dec 18.

PMID:
23249611
25.

Reliability and construct validity of three health-related self-report scales in HIV-positive adults in rural Rwanda.

Epino HM, Rich ML, Kaigamba F, Hakizamungu M, Socci AR, Bagiruwigize E, Franke MF.

AIDS Care. 2012;24(12):1576-83. doi: 10.1080/09540121.2012.661840. Epub 2012 Mar 19.

PMID:
22428702
26.

Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects.

Gammino VM, Taylor AB, Rich ML, Bayona J, Becerra MC, Bonilla C, Gelmanova I, Hollo V, Jaramillo E, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riektsina V, Tupasi TE, Wells CD, Zignol M, Cegielski PJ.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1315-22. doi: 10.5588/ijtld.10.0221.

PMID:
22283887
27.

Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda.

Rich ML, Miller AC, Niyigena P, Franke MF, Niyonzima JB, Socci A, Drobac PC, Hakizamungu M, Mayfield A, Ruhayisha R, Epino H, Stulac S, Cancedda C, Karamaga A, Niyonzima S, Yarbrough C, Fleming J, Amoroso C, Mukherjee J, Murray M, Farmer P, Binagwaho A.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):e35-42. doi: 10.1097/QAI.0b013e31824476c4.

PMID:
22156912
28.

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update.

Falzon D, Jaramillo E, Schünemann HJ, Arentz M, Bauer M, Bayona J, Blanc L, Caminero JA, Daley CL, Duncombe C, Fitzpatrick C, Gebhard A, Getahun H, Henkens M, Holtz TH, Keravec J, Keshavjee S, Khan AJ, Kulier R, Leimane V, Lienhardt C, Lu C, Mariandyshev A, Migliori GB, Mirzayev F, Mitnick CD, Nunn P, Nwagboniwe G, Oxlade O, Palmero D, Pavlinac P, Quelapio MI, Raviglione MC, Rich ML, Royce S, Rüsch-Gerdes S, Salakaia A, Sarin R, Sculier D, Varaine F, Vitoria M, Walson JL, Wares F, Weyer K, White RA, Zignol M.

Eur Respir J. 2011 Sep;38(3):516-28. doi: 10.1183/09031936.00073611. Epub 2011 Aug 4.

29.

High human immunodeficiency virus-free survival of infants born to human immunodeficiency virus-positive mothers in an integrated program to decrease child mortality in rural Rwanda.

Franke MF, Stulac SN, Rugira IH, Rich ML, Bucyibaruta JB, Drobac PC, Iyamungu G, Bryant CM, Binagwaho A, Farmer PE, Mukherjee JS.

Pediatr Infect Dis J. 2011 Jul;30(7):614-6. doi: 10.1097/INF.0b013e31820a599e.

PMID:
21206394
30.

Improving quality in resource poor settings: observational study from rural Rwanda.

Kotagal M, Lee P, Habiyakare C, Dusabe R, Kanama P, Epino HM, Rich ML, Farmer PE.

BMJ. 2009 Oct 30;339:b3488. doi: 10.1136/bmj.b3488.

PMID:
19880528
31.

Reduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of community-based malaria control programme in rural Rwanda.

Sievers AC, Lewey J, Musafiri P, Franke MF, Bucyibaruta BJ, Stulac SN, Rich ML, Karema C, Daily JP.

Malar J. 2008 Aug 27;7:167. doi: 10.1186/1475-2875-7-167.

32.

Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study.

Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Atwood S, Mukherjee JS, Rich ML, Furin JJ, Nardell EA, Kim JY, Shin SS.

Lancet. 2008 Oct 18;372(9647):1403-9. doi: 10.1016/S0140-6736(08)61204-0. Epub 2008 Aug 22.

PMID:
18723218
33.

Comprehensive treatment of extensively drug-resistant tuberculosis.

Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, Fitzmaurice GM, Alcantara Viru FA, Appleton SC, Bayona JN, Bonilla CA, Chalco K, Choi S, Franke MF, Fraser HS, Guerra D, Hurtado RM, Jazayeri D, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Sloutsky A, Becerra MC.

N Engl J Med. 2008 Aug 7;359(6):563-74. doi: 10.1056/NEJMoa0800106.

34.

Reduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of a community-based malaria control programme in rural Rwanda.

Sievers AC, Lewey J, Musafiri P, Franke MF, Bucyibaruta BJ, Stulac SN, Rich ML, Karema C, Daily JP.

World Hosp Health Serv. 2008;44(4):28-35.

PMID:
19370834
35.

Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia.

Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Yedilbayev A, Rich ML, Mukherjee JS, Furin JJ, Atwood S, Farmer PE, Keshavjee S.

Int J Tuberc Lung Dis. 2007 Dec;11(12):1314-20.

PMID:
18034952
36.

Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.

Keshavjee S, Gelmanova IY, Pasechnikov AD, Mishustin SP, Andreev YG, Yedilbayev A, Furin JJ, Mukherjee JS, Rich ML, Nardell EA, Farmer PE, Kim JY, Shin SS.

Ann N Y Acad Sci. 2008;1136:1-11. Epub 2007 Oct 22.

PMID:
17954675
37.

Multidrug-resistant tuberculosis management in resource-limited settings.

Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC.

Emerg Infect Dis. 2006 Sep;12(9):1389-97.

38.

Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.

Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Nikiforov M, Yedilbayev A, Mukherjee JS, Furin JJ, Barry DJ, Farmer PE, Rich ML, Keshavjee S.

Int J Tuberc Lung Dis. 2006 Apr;10(4):402-8. Erratum in: Int J Tuberc Lung Dis. 2006 Oct;10(10):1183. Mishustin, S [added]; Barnashov, A [added]; Karpeichik, Y [added].

PMID:
16602404
39.

Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB.

Rich ML, Socci AR, Mitnick CD, Nardell EA, Becerra MC, Bonilla C, Bayona J, Seung KJ, Furin J, Farmer PE, Mukherjee JS.

Int J Tuberc Lung Dis. 2006 Mar;10(3):290-6.

PMID:
16562709
40.

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V, Zarovska E, Rich ML, Fraser HS, Alarcón E, Cegielski JP, Grzemska M, Gupta R, Espinal M.

Int J Tuberc Lung Dis. 2005 Jun;9(6):640-5.

PMID:
15971391
41.

Retreatment management strategies when first-line tuberculosis therapy fails.

Saravia JC, Appleton SC, Rich ML, Sarria tM, Bayona J, Becerra MC.

Int J Tuberc Lung Dis. 2005 Apr;9(4):421-9.

PMID:
15830748
42.

Programmes and principles in treatment of multidrug-resistant tuberculosis.

Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, Bayona J, Farmer P, Smith Fawzi MC, Seung KJ.

Lancet. 2004 Feb 7;363(9407):474-81. Review.

PMID:
14962530
43.

Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru.

Mukherjee JS, Joseph JK, Rich ML, Shin SS, Furin JJ, Seung KJ, Sloutsky A, Socci AR, Vanderwarker C, Vasquez L, Palacios E, Guerra D, Viru FA, Farmer P, Del Castillo HE.

Int J Tuberc Lung Dis. 2003 Jul;7(7):637-44.

PMID:
12870684
44.

From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift.

Kim JY, Mukherjee JS, Rich ML, Mate K, Bayona J, Becerra MC.

Tuberculosis (Edinb). 2003;83(1-3):59-65. Review.

PMID:
12758190
45.
46.
47.

Anti-tumor vaccine adjuvant effects of IL-2 liposomes in mice immunized against MCA-102 sarcoma.

Sencer SF, Rich ML, Katsanis E, Ochoa AC, Anderson PM.

Eur Cytokine Netw. 1991 Nov-Dec;2(5):311-8.

PMID:
1804322
48.

Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation.

Katsanis E, Anderson PM, Filipovich AH, Hasz DE, Rich ML, Loeffler CM, Ochoa AC, Weisdorf DJ.

Blood. 1991 Sep 1;78(5):1286-91.

49.

Haematological reactions to drug therapy.

RICH ML.

J Ky State Med Assoc. 1957 Feb;55(2):142-6. No abstract available.

PMID:
13406354
50.

A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy.

RICH ML, RITTERHOFF RJ, HOFFMANN RJ.

Ann Intern Med. 1950 Dec;33(6):1459-67. No abstract available.

PMID:
14790529

Supplemental Content

Support Center